NanoVibronix, Inc. (NASDAQ:NAOV) Sees Large Increase in Short Interest

NanoVibronix, Inc. (NASDAQ:NAOV) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 515,200 shares, an increase of 3,311.9% from the September 30th total of 15,100 shares. Based on an average trading volume of 121,900 shares, the days-to-cover ratio is presently 4.2 days. Currently, 18.7% of the company’s shares are sold short.

NanoVibronix Price Performance

Shares of NASDAQ:NAOV traded up $0.03 during midday trading on Friday, reaching $0.55. 91,317 shares of the company’s stock were exchanged, compared to its average volume of 82,782. The stock has a market cap of $1.52 million, a price-to-earnings ratio of -0.42 and a beta of 1.50. NanoVibronix has a fifty-two week low of $0.46 and a fifty-two week high of $1.55. The firm’s 50 day simple moving average is $0.60 and its two-hundred day simple moving average is $0.69.

NanoVibronix (NASDAQ:NAOV) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.25) earnings per share for the quarter. The company had revenue of $0.82 million for the quarter. NanoVibronix had a negative return on equity of 74.98% and a negative net margin of 83.49%.

About NanoVibronix

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.